Sales and Production Activities While Preventing COVID-19 Infections
First written in FY2021-Q1. 10 of 12 entries say "Restated". Latest entry: FY2024.
19 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual report
「As a result of conducting sales and production activities, the Group reported revenue of ¥7,448 million for the fiscal year, down ¥451 million, or 5.7%, from the previous fiscal year, and orders received of ¥7,858 million, down ¥9 million, or 0.1%.」
The previous description of sales and production activities as being conducted “while taking every possible precaution to prevent COVID-19 infections” is not explicitly included in the full-year disclosure for the fiscal year. - FY2023-Q3RestatedAnnual report
「As a result of conducting sales and production activities while taking every possible precaution to prevent COVID-19 infections, the Group」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2023-Q2RestatedAnnual report
「The Group conducted sales and production activities while taking every possible precaution to prevent COVID-19 infections.」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2023-Q1RestatedAnnual report
「As a result of conducting sales and production activities while taking every possible precaution to prevent COVID-19 infections, the Group」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2022RestatedAnnual report
「As a result of conducting sales and production activities while taking every possible precaution to prevent COVID-19 infections, the Group reported revenue of ¥8,506 million for the fiscal year, compared with ¥9,591 million in the previous fiscal year, and orders received of ¥9,582 million, compared with ¥9,575 million in the previous fiscal year.」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2022-Q3RestatedAnnual report
「As a result of conducting sales and production activities while taking every possible precaution to prevent COVID-19 infections, the Group」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2022-Q2RestatedAnnual report
「The Group conducted sales and production activities while taking every possible precaution to prevent COVID-19 infections.」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2022-Q1RestatedAnnual report
「The Group conducted sales and production activities while taking every possible precaution to prevent COVID-19 infections.」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2021RestatedAnnual report
「As a result of conducting sales and production activities while taking every possible precaution to prevent COVID-19 infections, the Group reported revenue of ¥9,591 million for the fiscal year, down ¥275 million, or 2.8%, from the previous fiscal year, and orders received of ¥9,575 million, down ¥1,967 million, or 17.0%.」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2021-Q3RestatedAnnual report
「As a result of conducting sales and production activities while taking every possible precaution to prevent COVID-19 infections, the Group reported revenue of ¥6,765 million for the nine-month period ended December 2021, down ¥48 million, or 0.7%, from the same period of the previous year, and orders received of ¥8,401 million, down ¥1,404 million, or 14.3%.」
It continues sales and production activities while taking precautions to prevent COVID-19 infections. - FY2021-Q2RestatedAnnual report
「Against this backdrop, the Group conducted sales and production activities while taking every possible precaution to prevent COVID-19 infections.」
It continued sales and production activities during the six-month period ended September 2021 while taking precautions to prevent COVID-19 infections. - FY2021-Q1First statedAnnual report
「The Group conducted sales and production activities while taking every possible precaution to prevent COVID-19 infections.」
It describes for the first time the policy of continuing sales and production activities while taking precautions to prevent COVID-19 infections.